Mary E Lott1, Julia E Slocomb2, Zhaohui Gao3, Robert A Gabbay4, David Quillen5, Thomas W Gardner6, Kerstin Bettermann7. 1. Penn State Hershey Medical Center, Heart and Vascular Institute, Hershey, PA 17033, USA. Electronic address: mlott@hmc.psu.edu. 2. John Hopkins University, Department of Biology, Baltimore, MD 21218, USA. 3. Penn State Hershey Medical Center, Heart and Vascular Institute, Hershey, PA 17033, USA. 4. Joslin Diabetes Center, Harvard Medical School, Boston, MA 02116, USA. 5. Penn State Hershey Medical Center, Department of Ophthalmology, Hershey, PA 17033, USA. 6. University of Michigan, Kellogg Eye Center, Ann Arbor, MI 48105, USA. 7. Penn State Hershey Medical Center, Department of Neurology, Hershey, PA 17033, USA.
Abstract
PURPOSE: Adults with diabetes are at a high risk of developing coronary heart disease. The purpose of this study was to assess coronary artery vascular function non-invasively in individuals with and without Type 2 diabetes and to compare these coronary responses to another microvascular bed (i.e. retina). We hypothesized that individuals with diabetes would have impaired coronary reactivity and that these impairments would be associated with impairments in retinal reactivity. METHODS: Coronary blood velocity (Transthoracic Doppler Echocardiography) and retinal diameters (Dynamic Vessel Analyzer) were measured continuously during five minutes of breathing 100% oxygen (i.e. hyperoxia) in 15 persons with Type 2 diabetes and 15 age-matched control subjects. Using fundus photographs, retinal vascular calibers were also measured (central retinal arteriole and venule equivalents). RESULTS: Individuals with diabetes compared to controls had impaired coronary (-2.34±16.64% vs. -14.27±10.58%, P=0.03) and retinal (arteriole: -0.04±3.34% vs. -3.65±5.07%, P=0.03; venule: -1.65±3.68% vs. -5.23±5.47%, P=0.05) vasoconstrictor responses to hyperoxia, and smaller central arteriole-venule equivalent ratios (0.83±0.07 vs. 0.90±0.07, P=0.014). Coronary reactivity was associated with central retinal arteriole equivalents (r=-0.516, P=0.005) and retinal venular reactivity (r=0.387, P=0.034). CONCLUSION: Diabetes impairs coronary and retinal microvascular function to hyperoxia. Impaired vasoconstrictor responses may be part of a systemic diabetic vasculopathy, which may contribute to adverse cardiovascular events in individuals with diabetes.
PURPOSE: Adults with diabetes are at a high risk of developing coronary heart disease. The purpose of this study was to assess coronary artery vascular function non-invasively in individuals with and without Type 2 diabetes and to compare these coronary responses to another microvascular bed (i.e. retina). We hypothesized that individuals with diabetes would have impaired coronary reactivity and that these impairments would be associated with impairments in retinal reactivity. METHODS: Coronary blood velocity (Transthoracic Doppler Echocardiography) and retinal diameters (Dynamic Vessel Analyzer) were measured continuously during five minutes of breathing 100% oxygen (i.e. hyperoxia) in 15 persons with Type 2 diabetes and 15 age-matched control subjects. Using fundus photographs, retinal vascular calibers were also measured (central retinal arteriole and venule equivalents). RESULTS: Individuals with diabetes compared to controls had impaired coronary (-2.34±16.64% vs. -14.27±10.58%, P=0.03) and retinal (arteriole: -0.04±3.34% vs. -3.65±5.07%, P=0.03; venule: -1.65±3.68% vs. -5.23±5.47%, P=0.05) vasoconstrictor responses to hyperoxia, and smaller central arteriole-venule equivalent ratios (0.83±0.07 vs. 0.90±0.07, P=0.014). Coronary reactivity was associated with central retinal arteriole equivalents (r=-0.516, P=0.005) and retinal venular reactivity (r=0.387, P=0.034). CONCLUSION:Diabetes impairs coronary and retinal microvascular function to hyperoxia. Impaired vasoconstrictor responses may be part of a systemic diabetic vasculopathy, which may contribute to adverse cardiovascular events in individuals with diabetes.
Authors: B Takase; A Uehata; T Akima; T Nagai; T Nishioka; A Hamabe; K Satomura; F Ohsuzu; A Kurita Journal: Am J Cardiol Date: 1998-12-15 Impact factor: 2.778
Authors: Patrick H McNulty; Bryan J Robertson; Mark A Tulli; Joshua Hess; Lisa A Harach; Sofia Scott; Lawrence I Sinoway Journal: J Appl Physiol (1985) Date: 2007-02-15
Authors: Patrick H McNulty; Nicholas King; Sofia Scott; Gretchen Hartman; Jennifer McCann; Mark Kozak; Charles E Chambers; Laurence M Demers; Lawrence I Sinoway Journal: Am J Physiol Heart Circ Physiol Date: 2005-03 Impact factor: 4.733
Authors: Tien Yin Wong; Bruce B Duncan; Sherita Hill Golden; Ronald Klein; David J Couper; Barbara E K Klein; Larry D Hubbard; A Richey Sharrett; Maria I Schmidt Journal: Invest Ophthalmol Vis Sci Date: 2004-09 Impact factor: 4.799
Authors: Thomas H Schindler; Egbert U Nitzsche; Manfred Olschewski; Nobuhisa Magosaki; Michael Mix; John O Prior; Alvaro D Facta; Ulrich Solzbach; Hanjoerg Just; Heinrich R Schelbert Journal: Circulation Date: 2004-08-16 Impact factor: 29.690
Authors: Samuel A Mills; Andrew I Jobling; Michael A Dixon; Bang V Bui; Kirstan A Vessey; Joanna A Phipps; Ursula Greferath; Gene Venables; Vickie H Y Wong; Connie H Y Wong; Zheng He; Flora Hui; James C Young; Josh Tonc; Elena Ivanova; Botir T Sagdullaev; Erica L Fletcher Journal: Proc Natl Acad Sci U S A Date: 2021-12-21 Impact factor: 11.205
Authors: Bob Smit; Yvo M Smulders; Etto C Eringa; Heleen M Oudemans-van Straaten; Armand R J Girbes; Kimberley E Wever; Carlijn R Hooijmans; Angelique M E Spoelstra-de Man Journal: Crit Care Date: 2018-08-04 Impact factor: 9.097